Axq Capital, LP Fate Therapeutics Inc Transaction History

Axq Capital, LP

  • $331 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$3.54 - $8.35 $72,216 - $170,340
20,400 New
20,400 $150 Million
Q1 2023

May 10, 2023
SELL
$4.24 - $11.12 $221,222 - $580,186
-52,175 Reduced 76.57%
15,964 $91 Million
Q4 2022

Feb 10, 2023
BUY
$9.86 - $23.83 $671,850 - $1.62 Million
68,139 New
68,139 $688 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $163M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email